BN Business News
Kompaniya qo‘shish →

Biznes · 17/11/20261 daq o‘qish

Onward Therapeutics NT$900 million (taxminan 28 million AQSH) B-sinf finansirovaniyani yakunladi va klinika darajasidagi onkologiya pipeline-ni rivojlantirish uchun xodisalarni davom ettiradi

Mahalliy avtomatik tarjima · Manbaning asl tili

EDITORIAL ILLUSTRATIONBBiznesBN
Illustration generated by Business News; it is not a source photograph.

Xulosa

Onward Therapeutics global ma'muriyatini Tayvan ga ko'chirganidan keyin birinchi marta kapitalni oshirgan; Kompaniya 2027-yil oxirigacha Yangi Sharq bozori hisobga olinuvchi hissadorlar paneliga (Emerging Stock Board) ro'yxatdan o'tishni maqsad qilmoqda. TAIPEI, EPALINGES va PARIS, 2026-yil 17-november — Onward Therapeutics, Inc. ("Onward Therapeutics" yoki "Kompaniya") bugun...

Manbaning asl tili: PR Newswire UK — News ReleasesAsl bayonotni ochish →

Explore insights

Business insights →